June 22, 2021
World Intellectual Property Review
The Supreme Court of the United States’ Arthrex decision determined that Patent Trial and Appeal Board (PTAB) Administrative Patent Judges (APJs) were unconstitutionally appointed. As a remedy, the Supreme Court handed power to the U.S. Patent and Trademark Office (USPTO) director to assess inter partes review (IPR) decisions. World IP Review interviewed Finnegan partner Derek McCorquindale for his thoughts on the decision.
Derek said, “The director’s authority is executive and remains circumscribed to allow the U.S. President to maintain adequate control, including the power of direct removal. Additionally, any review conducted by the director will still be subject to judicial review at the United States Court of Appeals for the Federal Circuit.”
Read “Arthrex: ‘Patents Have Become More Political’”
United States v. Arthrex, Arthrex v. Smith & Nephew , Supreme Court of the United States (SCOTUS), Patent Trial and Appeal Board (PTAB), administrative patent judge (APJ)
Award/Ranking
Best Lawyers in Germany Recognizes Dr. Dr. Jochen Herr in Recent Rankings
July 16, 2026
Commentary
Patent Strategy Could Shape Financing, Valuation and Risk in Offshore Energy Projects
June 30, 2026
Award/Ranking
Finnegan’s European Practices and Attorneys Highlighted in 2026 Managing IP Rankings
June 25, 2026
Press Release
BMW Obtains Preliminary Injunction Against Zync; Federal Court Orders Zync to Halt ITC Trade Secret
June 23, 2026
Award/Ranking
Six Finnegan Partners Recognized in the 2026 Lawdragon 500 Leading Global IP Lawyers
June 22, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.